Hypocretin/orexin regulation of dopamine signaling: Implications for reward and reinforcement mechanisms

Frontiers in Behavioral Neuroscience

Volumn , Issue AUGUST, 2012, Pages

  Calipari, Erin S ^a   España, Rodrigo A ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cocaine; Hypocretin; Orexin; Reward; Self administration; Ventral tegmental area; Voltammetry

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; AMPHETAMINE; COCAINE; DOPAMINE; METHAMPHETAMINE; NICOTINE; OREXIN;

AROUSAL; BEHAVIOR CONTROL; BEHAVIORAL SCIENCE; COCAINE DEPENDENCE; DOPAMINE UPTAKE; DRUG EFFICACY; DRUG MECHANISM; DRUG SEEKING BEHAVIOR; LATERAL HYPOTHALAMUS; LOCOMOTION; MESOLIMBIC DOPAMINERGIC SYSTEM; METHAMPHETAMINE DEPENDENCE; MORPHINE ADDICTION; MOTIVATION; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PLACE PREFERENCE; PROTEIN FUNCTION; REINFORCEMENT; REINSTATEMENT; REVIEW; REWARD; SIGNAL TRANSDUCTION; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM;

EID: 84864953752     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2012.00054     Document Type: Review

References (84)

1. Adamantidis, A. R., Zhang, F., Aravanis, A. M., Deisseroth, K., de, L. L. (2007). Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450, 420-424.
2. Aragona, B. J., Cleaveland, N. A., Stuber, G. D., Day, J. J., Carelli, R. M., Wightman, R. M. (2008). Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J. Neurosci. 28, 8821-8831.
3. Aston-Jones, G., Smith, R. J., Moorman, D. E., Richardson, K. A. (2009). Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 56 Suppl 1, 112-121.
4. Backberg, M., Hervieu, G., Wilson, S., Meister, B. (2002). Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake. Eur.J. Neurosci. 15, 315-328.
5. Baldo, B. A., Daniel, R. A., Berridge, C. W., Kelley, A. E. (2003). Overlapping distributions of orexin/hypocretin-and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J. Comp Neurol. 464, 220-237.
6. Borgland, S. L., Chang, S. J., Bowers, M. S., Thompson, J. L., Vittoz, N., Floresco, S. B., Chou, J., Chen, B. T., Bonci, A. (2009). Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J. Neurosci. 29, 11215-11225.
7. Borgland, S. L., Storm, E., Bonci, A. (2008). Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. Eur. J Neurosci. 28, 1545-1556.
8. Borgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., Bonci, A. (2006). Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49, 589-601.
9. Bourgin, P., Huitron-Resendiz, S., Spier, A. D., Fabre, V., Morte, B., Criado, J. R., Sutcliffe, J. G., Henriksen, S. J., de Lecea, L. (2000). Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci. 20, 7760-7765.
10. Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., de Lecea, L. (2005). Role for hypocretin in mediating stress-induced reinstatement of cocaineseeking behavior. Proc. Natl. Acad. Sci.U.S. A 102, 19168-19173.
11. Cluderay, J. E., Harrison, D. C., Hervieu, G. J. (2002). Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul. Pept. 104, 131-144.
12. Corrigall, W. A. (2009). Hypocretin mechanisms in nicotine addiction: evidence and speculation. Psychopharmacology (Berl) 206, 23-37.
13. Crombag, H. S., Grimm, J. W., Shaham, Y. (2002). Effect of dopamine receptor antagonists on renewal of cocaine seeking by reexposure to drug-associated contextual cues. Neuropsychopharmacology 27, 1006-1015.
14. Dayas, C. V., McGranahan, T. M., Martin-Fardon, R., Weiss, F. (2008). Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol. Psychiatry 63, 152-157.
15. De Lecea, L., Kilduff, T. S., Peyron, C., Gao, X., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L., Gautvik, V. T., Bartlett, F. S., Frankel, W. N., van Den Pol, A. N., Bloom, F. E., Gautvik, K. M., Sutcliffe, J. G. (1998). The hypocretins: hypothalamusspecific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci.U.S. A 95, 322-327.
16. Deng, B. S., Nakamura, A., Zhang, W., Yanagisawa, M., Fukuda, Y., Kuwaki, T. (2007). Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice. J. Appl. Physiol 103, 1772-1779.
17. Dickinson, S. D., Sabeti, J., Larson, G. A., Giardina, K., Rubinstein, M., Kelly, M. A., Grandy, D. K., Low, M. J., Gerhardt, G. A., Zahniser, N. R. (1999). Dopamine D2 receptordeficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72, 148-156.
18. Dugovic, C., Shelton, J. E., Aluisio, L. E., Fraser, I. C., Jiang, X., Sutton, S. W., Bonaventure, P., Yun, S., Li, X., Lord, B., Dvorak, C. A., Carruthers, N. I., Lovenberg, T. W. (2009). Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J. Pharmacol. Exp. Ther. 330, 142-151.
19. España, R. A., Baldo, B. A., Kelley, A. E., Berridge, C. W. (2001). Wake-promoting and sleepsuppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106, 699-715.
20. España, R. A., Melchior, J. R., Roberts, D. C. S., Jones, S. R. (2011). Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology 1-12.
21. España, R. A., Oleson, E. B., Locke, J. L., Brookshire, B. R., Roberts, D. C. S., Jones, S. R. (2010). The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur.J. Neurosci. 31, 336-348.
22. España, R. A., Jones, S. R. (2010). Hypocretin / orexin knockout mice display disrupted dopamine responses to cocaine. Society for Neuroscience San Diego, CA:668.14.
23. Fadel, J., Deutch, A. Y. (2002). Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111, 379-387.
24. Furman, C. A., Chen, R., Guptaroy, B., Zhang, M., Holz, R. W., Gnegy, M. (2009). Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: livecell imaging using total internal reflection fluorescence microscopy. J. Neurosci. 29, 3328-3336.
25. Georgescu, D., Zachariou, V., Barrot, M., Mieda, M., Willie, J. T., Eisch, A. J., Yanagisawa, M., Nestler, E. J., DiLeone, R. J. (2003). Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci. 23, 3106-3111.
26. Greco, M. A., Shiromani, P. J. (2001). Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Brain Res Mol. Brain Res 88, 176-182.
27. Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benham, C. D., Taylor, S. G., Routledge, C., Hemmati, P., Munton, R. P., Ashmeade, T. E., Shah, A. S., Hatcher, J. P., Hatcher, P. D., Jones, D. N., Smith, M. I., Piper, D. C., Hunter, A. J., Porter, R. A., Upton, N. (1999). Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci.U.S. A 96, 10911-10916.
28. Harris, G. C., Aston-Jones, G. (2006). Arousal and reward: a dichotomy in orexin function. Trends Neurosci. 29, 571-577.
29. Harris, G. C., Wimmer, M., Aston-Jones, G. (2005). A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437, 556-559.
30. Harris, G. C., Wimmer, M., Randall-Thompson, J. F., Aston-Jones, G. (2007). Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav. Brain Res 183, 43-51.
31. Hervieu, G. J., Cluderay, J. E., Harrison, D. C., Roberts, J. C., Leslie, R. A. (2001). Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103, 777-797.
32. Hollander, J. A., Lu, Q., Cameron, M. D., Kamenecka, T. M., Kenny, P. J. (2008). Insular hypocretin transmission regulates nicotine reward. Proc. Natl. Acad. Sci.U.S. A 105, 19480-19485.
33. Hutcheson, D. M., Quarta, D., Halbout, B., Rigal, A., Valerio, E., Heidbreder, C. (2011). Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaineconditioned reinforcement and the expression of amphetamine-conditioned reward. Behav. Pharmacol. 22, 173-181.
34. Ivanov, A., Aston-Jones, G. (2000). Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons. Neuroreport 11, 1755-1758.
35. James, M. H., Charnley, J. L., Levi, E. M., Jones, E., Yeoh, J. W., Smith, D. W., Dayas, C. V. (2011). Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaineseeking. Int.J. Neuropsychopharmacol. 14, 684-690.
36. Johnson, L. A., Furman, C. A., Zhang, M., Guptaroy, B., Gnegy, M. E. (2005). Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation. Neuropharmacology 49, 750-758.
37. Kalivas, P. W., Striplin, C. D., Steketee, J. D., Klitenick, M. A., Duffy, P. (1992). Cellular mechanisms of behavioral sensitization to drugs of abuse. Ann.N.Y. Acad. Sci. 654, 128-135.
38. Kane, J. K., Parker, S. L., Matta, S. G., Fu, Y., Sharp, B. M., Li, M. D. (2000). Nicotine upregulates expression of orexin and its receptors in rat brain. Endocrinology 141, 3623-3629.
39. Ko, E. M., Estabrooke, I. V., McCarthy, M., Scammell, T. E. (2003). Wake-related activity of tuberomammillary neurons in rats. Brain Res. 992, 220-226.
40. Koob, G. F., Le Moal, M. (1997). Drug abuse: hedonic homeostatic dysregulation. Science 278, 52-58.
41. Korotkova, T. M., Brown, R. E., Sergeeva, O. A., Ponomarenko, A. A., Haas, H. L. (2006). Effects of arousal-and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur.J. Neurosci. 23, 2677-2685.
42. Korotkova, T. M., Sergeeva, O. A., Eriksson, K. S., Haas, H. L., Brown, R. E. (2003). Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci. 23, 7-11.
43. Lawrence, A. J., Cowen, M. S., Yang, H. J., Chen, F., Oldfield, B. (2006). The orexin system regulates alcohol-seeking in rats. Br.J. Pharmacol. 148, 752-759.
44. Lee, F. J., Pei, L., Moszczynska, A., Vukusic, B., Fletcher, P. J., Liu, F. (2007). Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J. 26, 2127-2136.
45. Li, L. B., Chen, N., Ramamoorthy, S., Chi, L., Cui, X. N., Wang, L. C., Reith, M. E. (2004). The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279, 21012-21020.
46. Mahler, S. V., Smith, R. J., Aston-Jones, G. (2012). Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl).
47. Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., Elmquist, J. K. (2001). Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp Neurol. 435, 6-25.
48. McPherson, C. S., Featherby, T., Krstew, E., Lawrence, A. J. (2007). Quantification of phosphorylated cAMP-response element-binding protein expression throughout the brain of amphetamine-sensitized rats: activation of hypothalamic orexin A-containing neurons. J. Pharmacol. Exp. Ther. 323, 805-812.
49. Meiergerd, S. M., Patterson, T. A., Schenk, J. O. (1993). D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61, 764-767.
50. Moorman, D. E., Aston-Jones, G. (2010). Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences. J. Neurosci. 30, 15585-15599.
51. Mortensen, O. V., Larsen, M. B., Prasad, B. M., Amara, S. G. (2008). Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking. Mol. Biol. Cell 19, 2818-2829.
52. Narita, M., Nagumo, Y., Hashimoto, S., Narita, M., Khotib, J., Miyatake, M., Sakurai, T., Yanagisawa, M., Nakamachi, T., Shioda, S., Suzuki, T. (2006). Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci. 26, 398-405.
53. Norman, A. B., Tsibulsky, V. L. (2006). The compulsion zone: a pharmacological theory of acquired cocaine self-administration. Brain Res. 1116, 143-152.
54. Pasumarthi, R. K., Reznikov, L. R., Fadel, J. (2006). Activation of orexin neurons by acute nicotine. Eur.J. Pharmacol. 535, 172-176.
55. Peyron, C., Tighe, D. K., van Den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., Kilduff, T. S. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996-10015.
56. Piper, D. C., Upton, N., Smith, M. I., Hunter, A. J. (2000). The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur.J. Neurosci. 12, 726-730.
57. Plaza-Zabala, A., Martin-Garcia, E., de, L. L., Maldonado, R., Berrendero, F. (2010). Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J. Neurosci. 30, 2300-2310.
58. Quarta, D., Valerio, E., Hutcheson, D. M., Hedou, G., Heidbreder, C. (2010). The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization. Neurochem. Int. 56, 11-15.
59. Rasmussen, K., Hsu, M. A., Noone, S., Johnson, B. G., Thompson, L. K., Hemrick-Luecke, S. K. (2007). The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the treatment of extrapyramidal symptoms. Schizophr. Bull. 33, 1291-1297.
60. Richards, J. K., Simms, J. A., Steensland, P., Taha, S. A., Borgland, S. L., Bonci, A., Bartlett, S. E. (2008). Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 199, 109-117.
61. Richardson, N. R., Roberts, D. C. S. (1996). Progressive ratio schedules in drug selfadministration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods 66, 1-11.
62. Ritz, M. C., Lamb, R. J., Goldberg, S. R., Kuhar, M. J. (1987). Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223.
63. Roberts, D. C. S., Brebner, K., Vincler, M., Lynch, W. J. (2002). Patterns of cocaine selfadministration in rats produced by various access conditions under a discrete trials procedure. Drug Alcohol Depend. 67, 291-299.
64. Roberts, D. C. S., Corcoran, M. E., Fibiger, H. C. (1977). On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6, 615-620.
65. Robinson, T. E., Berridge, K. C. (1993). The neural basis of drug craving: an incentivesensitization theory of addiction. Brain Res. Brain Res. Rev. 18, 247-291.
66. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richarson, J. A., Kozlowski, G. P., Wilson, S., Arch, J. R., Buckingham, R. E., Haynes, A. C., Carr, S. A., Annan, R. S., McNulty, D. E., Liu, W. S., Terrett, J. A., Elshourbagy, N. A., Bergsma, D. J., Yanagisawa, M. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 1.
67. Sartor, G. C., Aston-Jones, G. S. (2012). A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference. J. Neurosci. 32, 4623-4631.
68. Sharf, R., Guarnieri, D. J., Taylor, J. R., DiLeone, R. J. (2010). Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization. Brain Res. 1317, 24-32.
69. Sharf, R., Sarhan, M., DiLeone, R. J. (2008). Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol. Psychiatry 64, 175-183.
70. Smart, D., Sabido-David, C., Brough, S. J., Jewitt, F., Johns, A., Porter, R. A., Jerman, J. C. (2001). SB-334867-A: the first selective orexin-1 receptor antagonist. Br.J. Pharmacol. 132, 1179-1182.
71. Smith, R. J., Aston-Jones, G. (2012). Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur.J. Neurosci. 35, 798-804.
72. Smith, R. J., See, R. E., Aston-Jones, G. (2009). Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur.J. Neurosci. 30, 493-503.
73. Smith, R. J., Tahsili-Fahadan, P., Aston-Jones, G. (2010). Orexin/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology 58, 179-184.
74. Suzuki, R., Shimojima, H., Funahashi, H., Nakajo, S., Yamada, S., Guan, J. L., Tsurugano, S., Uehara, K., Takeyama, Y., Kikuyama, S., Shioda, S. (2002). Orexin-1 receptor immunoreactivity in chemically identified target neurons in the rat hypothalamus. Neurosci. Lett. 324, 5-8.
75. Trivedi, P., Yu, H., MacNeil, D. J., Van der Ploeg, L. H., Guan, X. M. (1998). Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 438, 71-75.
76. Vezina, P., Queen, A. L. (2000). Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area. Psychopharmacology (Berl) 151, 184-191.
77. Vittoz, N. M., Berridge, C. W. (2006). Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 31, 384-395.
78. Vittoz, N. M., Schmeichel, B., Berridge, C. W. (2008). Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. Eur.J. Neurosci. 28, 1629-1640.
79. Volkow, N. D., Wise, R. A. (2005). How can drug addiction help us understand obesity? Nat. Neurosci. 8, 555-560.
80. Wise, R. A. (1996). Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243-251.
81. Wise, R. A., Wang, B., You, Z. B. (2008). Cocaine serves as a peripheral interoceptive conditioned stimulus for central glutamate and dopamine release. PLoS. ONE. 3, e2846.
82. Woolverton, W. L., Johnson, K. M. (1992). Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13, 193-200.
83. Zhou, Y., Bendor, J., Hofmann, L., Randesi, M., Ho, A., Kreek, M. J. (2006). Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J. Endocrinol. 191, 137-145.
84. Zhu, Y., Miwa, Y., Yamanaka, A., Yada, T., Shibahara, M., Abe, Y., Sakurai, T., Goto, K. (2003). Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive Gproteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and-insensitive G-proteins. J. Pharmacol. Sci. 92, 259-266.